81864-14-4

Basic information

• Product Name: N-(6-Nitro-1,3-benzodioxol-5-yl)acetamide
• Synonyms: N-(6-Nitro-1,3-benzodioxol-5-yl)acetamide
• CAS NO: 81864-14-4
• Molecular Formula: C9H8N2O5
• Molecular Weight: 224
• Mol File: 81864-14-4.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-(6-Nitro-1,3-benzodioxol-5-yl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(6-Nitro-1,3-benzodioxol-5-yl)acetamide(81864-14-4)
• EPA Substance Registry System: N-(6-Nitro-1,3-benzodioxol-5-yl)acetamide(81864-14-4)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 81864-14-4(Hazardous Substances Data)

Usage

General Description

N-(6-Nitro-1,3-benzodioxol-5-yl)acetamide is a chemical compound with the molecular formula C10H8N2O5. It is a derivative of acetamide with a nitro group attached to a benzodioxole ring. N-(6-Nitro-1,3-benzodioxol-5-yl)acetamide is commonly used as a building block or intermediate in the production of various organic compounds, such as pharmaceuticals and agrochemicals. It has potential applications in pharmaceutical research and development for the synthesis of new drugs and therapeutic agents. Additionally, N-(6-Nitro-1,3-benzodioxol-5-yl)acetamide may also be used in academic or industrial research for the investigation of chemical reactions and processes.

Upstream product

• 14268-66-7 benzo[1,3]dioxolo-5-ylamine 
• 13067-19-1 3,4-methylenedioxyacetanilide 
• 108-24-7 acetic anhydride 

Downstream Products

• 64993-07-3 2-amino-4,5-methylenedioxy-1-nitrobenzene 

Relevant articles and documents

A Novel Difluoroacetic Acid Derivatives Compound, and Composition Comprising the Same

The present invention relates to a novel difluoroacetic acid derivative compound and a composition for various uses containing the same, wherein the difluoroacetic acid derivative compound can not only act as an agonist activating one among PPARandalpha;, andbeta; or andgamma;, but also can exhibit double efficacy or triple efficacy. Therefore, the difluoroacetic acid derivative compound can more effectively prevent, alleviate or treat metabolic diseases in which PPARs involves, and further exhibits whitening and wrinkle alleviation activity, and anti-inflammatory and antioxidant effects, thereby being able to be usefully utilized as various compositions.COPYRIGHT KIPO 2020

TRICYCLIC 1,2,4-TRIAZINE OXIDES AND COMPOSITIONS THEREFROM FOR THERAPEUTIC USE IN CANCER TREATMENTS

The invention relates to novel tricyclic 1,2,4-triazine-1-oxides and novel tricyclic 1,2,4-triazine-1,4-dioxides of formula: (I); and to related analogues, to their preparation, and to their use as hypoxia-selective drugs and radiosensitizers for cancer therapy, both alone or in combination with radiation and/or other anticancer drugs.